2025/10/10 14:35:08 – fort Lee, NJ – Stevenson Search Partners, a global life science executive search firm adn a Hunt Scanlon Top 50 ranked firm, assisted Apellis Pharmaceuticals in recruiting Leslie Meltzer as its new Chief Research and Development Officer.
Dr. MeltzerS Extensive Experience
Table of Contents
Dr. Meltzer brings a wealth of experience to Apellis,having consistently driven innovative therapies from initial revelation through to successful market launch. She has a proven track record in rare disease therapeutics and cell and gene therapy development, contributing to the launch of seven therapeutic products throughout her career.
Leadership Roles and Achievements
Most recently,Dr. Meltzer served as Chief Medical Officer at Orchard Therapeutics, where she provided strategic direction across development, medical affairs, regulatory affairs, diagnostics, and patient advocacy. She successfully lead the company to achieve global regulatory approvals.
Previous Positions
Prior to Orchard Therapeutics, Dr. Meltzer held senior leadership positions at:
- Keryx Biopharmaceuticals
- Biogen
- Actelion Pharmaceuticals
In thes roles, she consistently built and led medical affairs organizations, developing extensive launch strategies.
Stevenson Search Partners’ Role
Stevenson Search Partners leveraged its expertise in life science executive search to identify and recruit Dr. Meltzer, highlighting their commitment to connecting leading pharmaceutical companies with top-tier talent.
Key Takeaways
- Leslie Meltzer appointed as Chief R&D Officer at Apellis Pharmaceuticals.
- Dr. Meltzer has a strong background in rare disease and cell/gene therapy.
- She has successfully launched seven therapeutic products.
- Stevenson Search Partners facilitated the recruitment.